COMPARATIVE STUDY
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Neuromuscular control and exercise-related leg pain in triathletes.

UNLABELLED: Previous studies have shown that cycling can directly influence neuromuscular control during subsequent running in some highly trained triathletes. A relationship between this altered neuromuscular control of running and musculoskeletal pain and injury has been proposed; however, this link has not been investigated.

PURPOSE: This study aimed to evaluate the influence of cycling on neuromuscular control during subsequent running in highly trained triathletes with and without exercise-related leg pain (ERLP).

METHODS: Participants were 34 highly trained triathletes: 10 triathletes with a history of ERLP and 24 training-matched control triathletes with no history of ERLP. Knee and ankle kinematics and leg muscle recruitment were compared between a baseline run (no prior exercise) and a transition run (preceded by cycling; i.e., run vs cycle run).

RESULTS: Knee and ankle joint kinematics were not different between baseline and transition runs for any triathletes: absolute mean difference (+/-95% confidence interval) was 1.49 degrees +/- 0.17 degrees. However, muscle recruitment was different between baseline and transition runs, defined by absolute mean difference in EMG amplitude > or = 10%, in 5 of 24 control triathletes (11/130 muscles exhibited altered recruitment) and in 5 of 10 triathletes with a history of ERLP (12/50 muscles exhibited altered recruitment). This represents a relative risk of 2.40 (0.89-6.50; P = 0.089) when defined by athletes and 2.62 (1.34-6.01; P < 0.01) when defined by muscles. The magnitude of change in muscle recruitment between baseline and transition runs was not different between control (14.10% +/- 2.34%) and ERLP triathletes (16.31% +/- 3.64%; P = 0.41).

CONCLUSIONS: This study demonstrates an association between ERLP in triathletes and their neuromuscular control when running off the bike.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app